Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioTime, Inc. (NY: BTX)
4.380 USD  +0.200 (+4.78%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about BioTime, Inc.
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
BioTime Receives NIH Approval for Two GMP Human Embryonic Stem Cell Lines
June 03, 2011
from Business Wire News Releases
BioTime CEO Dr. Michael West to Present at the Jefferies 2011 Global Healthcare Conference
June 02, 2011
from Business Wire News Releases
20.0% Return Seen to Date on SmarTrend Biotime Call (BTX)
June 01, 2011
from Comtex SmarTrend® News Briefs
Biotonix annonce les résultats du premier trimestre de 2011
May 26, 2011
from Marketwired
Biotonix Announces First Quarter 2011 Results
May 26, 2011
from Marketwired
Biotonix : Assemblée annuelle et extraordinaire des actionnaires
May 24, 2011
from Marketwired
Biotonix: Annual and Special Meeting of Shareholders
May 24, 2011
from Marketwired
SmarTrend Vindicated on Biotime Downtrend Call: Stock Price Down 22.4% (BTX)
May 17, 2011
from Comtex SmarTrend® News Briefs
Morning Movers 05/16: (PRM) (VITA) (CISG) Higher; (SIHI) (CHLN) (NYX) Lower
May 16, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6507209 for the full story. Read More
from StreetInsider.com News Articles
Biotime Falls 0.33% on Heavy Volume: Watch For Potential Rebound (BTX)
May 11, 2011
from Comtex SmarTrend® News Briefs
Downtrend Call Realized As Biotime Stock Falls 8.1% (BTX)
May 10, 2011
from Comtex SmarTrend® News Briefs
BioTime Announces Issuance of U.S. Glycosan Hydrogel Patent
May 10, 2011
from Business Wire News Releases
BioTime Announces First Quarter 2011 Financial Results and Corporate Developments
May 05, 2011
from Business Wire News Releases
BioTime Initiates Clinical Development Program for HyStem®-Rx as a Cell Delivery Device for Reconstructive Surgery and Other Cell-Based Therapies
May 03, 2011
from Business Wire News Releases
BioTime Presents Data at FABS 2011 on the Restoration of Cell Lifespan Using iPS Cell Technology
April 12, 2011
from Business Wire News Releases
BioTime (BTX), Xennex Form New Stem Cell Development Joint Venture, LifeMap Sciences
April 06, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6413448 for the full story. Read More
from StreetInsider.com News Articles
BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine
April 05, 2011
from Business Wire News Releases
4 Cash-Rich Biotechs Smart Money Loves
March 29, 2011
Institutional buyers have been adding shares of these four biotechs, each with big stockpiles of cash to tide them over while their latest drugs and technologies are in trial and developmental stages. Read More
from MoneyShow.com
Biotonix annonce les résultats du quatrième trimestre et de la fin de l'exercice de 2010
March 25, 2011
from Marketwired
Biotonix Announces Results for the 2010 Fourth Quarter and Fiscal Year
March 25, 2011
from Marketwired
BioTime Announces the Closing of the Merger of Glycosan BioSystems with OrthoCyte Corporation
March 22, 2011
from Business Wire News Releases
BioTime, Inc. (BTX) Swings to Q4 Loss
March 15, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6367822 for the full story. Read More
from StreetInsider.com News Articles
BioTime Announces Fourth Quarter and Fiscal Year 2010 Financial Results and Corporate Developments
March 15, 2011
from Business Wire News Releases
BioTime CEO Michael West to Present at French-American Biotech Symposium, San Francisco, April 11-12, 2011
March 04, 2011
from Business Wire News Releases
Biotime: The Trend Continues Lower (BTX)
February 15, 2011
from Comtex SmarTrend® News Briefs
BioTime (BTX) Announces Merger Agreement with Glycosan BioSystems
February 14, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6288176 for the full story. Read More
from StreetInsider.com News Articles
BioTime Announces Agreement To Acquire Glycosan BioSystems
February 14, 2011
from Business Wire News Releases
Downtrend Spotted in Shares of Biotime (BTX)
February 08, 2011
from Comtex SmarTrend® News Briefs
BioTime (BTX) Announces $2.4M Acquisition of Cell Targeting Assets
January 28, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6242322 for the full story. Read More
from StreetInsider.com News Articles
BioTime Acquires Assets of Cell Targeting, Inc.
January 28, 2011
from Business Wire News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here